Kiniksa Pharmaceuticals International, plcKNSA
Market cap
$6.1B
P/E ratio
| 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Return on Assets | -56.2 | -53.4 | -54.2 | 53 | 2.9 | -7.8 |
| Return on equity (%) |
| 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Return on Assets | -56.2 | -53.4 | -54.2 | 53 | 2.9 | -7.8 |
| Return on equity (%) |